We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$417M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$43.8M |
| 2 |
Gilead Sciences
GILD
|
+$40.8M |
| 3 |
GE Aerospace
GE
|
+$37.3M |
| 4 |
Motorola Solutions
MSI
|
+$24.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$53.2M |
| 2 |
Amgen
AMGN
|
+$30.4M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$21.5M |
| 4 |
Canadian National Railway
CNI
|
+$20.9M |
| 5 |
Becton Dickinson
BDX
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.91% |
| 4 | Communication Services | 9.31% |
| 5 | Industrials | 8.11% |
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2017 Portfolio in Review
As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.
- Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
- Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
- Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
- Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
- Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
- Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.
Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.